Compare GeneDx Holdings Corp (WGS) vs Waste Management, Inc. (WM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GeneDx Holdings Corp vs Waste Management, Inc. — how do they compare? GeneDx Holdings Corp trades at $67.29 (market cap $2.02B), while Waste Management, Inc. trades at $208.63 (market cap $83.98B). The key difference: Waste Management, Inc. is far larger — about 41.6× GeneDx Holdings Corp's market cap, and Waste Management, Inc. pays a 1.8% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold GeneDx Holdings Corp for 19 Days and Waste Management, Inc. for 130 Days on average.
| WGS | WM | |
|---|---|---|
Market Cap | $2.02B | $83.98B |
Volume | 734,640 | 2,182,180 |
Sector | Health | Industrials |
52-Week High | $167.51 | $246.51 |
52-Week Low | $34.51 | $196.77 |
Typical Hold Time | 19 Days | 130 Days |
Enterprise Value | $2.05B | $106.78B |
Dividend Yield | — | 1.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GeneDx (WGS) trades at $68.09, down 0.64% today, with a bearish technical signal despite bullish oscillators showing oversold conditions. The company reported mixed Q2 2026 results with revenue beating expectations but negative profitability metrics, including a -23.4% net income margin. Recent news highlights product launches and industry recognition, while analyst consensus remains strongly bullish with a $81 price target.
The stock presents a growth opportunity in genomic testing with strong analyst support, but faces significant execution risks from persistent losses and high valuation multiples. Key catalysts include continued revenue growth and path to profitability, while risks include competitive pressures and cash flow challenges from negative operating cash flow in 2026.
Waste Management (WM) trades at $208.83, showing minimal daily movement with a slight decline of 0.05%. The stock maintains strong profitability metrics including a 29.83% ROE and 11.12% net margin, though valuation ratios appear elevated with a P/E of 29.72. Recent earnings show mixed performance with two beats and one miss in the last three quarters. Technical indicators suggest a bullish overall signal despite bearish moving averages, with key support at $208 and resistance at $212.
WM demonstrates resilient fundamentals with steady revenue growth and strong cash flow generation, though elevated debt levels and tight liquidity present concerns. Analyst consensus remains positive with 54% buy ratings and no sell recommendations. The company's essential service business model provides defensive characteristics, but investors should monitor debt management and competitive pressures in the waste management sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →About Waste Management, Inc.
Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →
